National Cancer Institute; Notice of Meeting, 69432-69433 [2013-27597]

Download as PDF 69432 Federal Register / Vol. 78, No. 223 / Tuesday, November 19, 2013 / Notices Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Transgenerational Inheritance, Spermatogenesis and Chemotherapy. Date: December 12, 2013. Time: 2:30 p.m. to 4:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Reed A Graves, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6166, MSC 7892, Bethesda, MD 20892, (301) 402– 6297, gravesr@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: November 13, 2013. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–27594 Filed 11–18–13; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Developmental Brain Disorders Study Section, October 24, 2013, 08:00 a.m. to October 25, 2013, 05:00 p.m., Melrose Hotel, 2430 Pennsylvania Avenue NW., Washington, DC, 20037 which was published in the Federal Register on October 1, 2013, 78 FR 60298. The meeting will be on November 26, 2013 from 11:00 a.m. to 3:00 p.m. at the National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. The meeting is closed to the public. Dated: November 13, 2013. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–27596 Filed 11–18–13; 8:45 am] BILLING CODE 4140–01–P TKELLEY on DSK3SPTVN1PROD with NOTICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Aging; Cancellation of Meeting Notice is hereby given of the cancellation of the National Institute on Aging Special Emphasis Panel, VerDate Mar<15>2010 17:21 Nov 18, 2013 Jkt 232001 December 18, 2013, 2:00 p.m. to December 18, 2013, 3:15 p.m., National Institute of Aging, Gateway Building, 7201 Wisconsin Avenue, Suite 2C212, Bethesda, MD 20892, which was published in the Federal Register on November 8, 2013, 67177 FR 217. The meeting was entitled Member Conflict. Dated: November 13, 2013. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–27598 Filed 11–18–13; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; Clinical Trials Review. Date: December 11, 2013. Time: 2:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Room 7188, Bethesda, MD 20892–7924 (Telephone Conference Call). Contact Person: Chang Sook Kim, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7188, Bethesda, MD 20892–7924, 301–435– 0287, carolko@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS). PO 00000 Frm 00071 Fmt 4703 Sfmt 4703 Dated: November 13, 2013. Michelle Trout, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–27592 Filed 11–18–13; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the President’s Cancer Panel. The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. Name of Committee: President’s Cancer Panel. Date: March 3, 2014. Time: 8:30 a.m. to 4:00 p.m. Agenda: Cancer Communication in the Digital Era: Opportunities and Challenges. Place: National Institutes of Health, 9000 Rockville Pike, Building 31, C-Wing, 6th Floor, Conference Room 10, Bethesda, MD 20892. Contact Person: Abby B. Sandler, Ph.D., Executive Secretary, President’s Cancer Panel, Special Assistant to the Director, NCI Center for Cancer Research, 9000 Rockville Pike, Building 31, Room B2B37, MSC 2590, Bethesda, MD 20892–8349, (301) 451–9399, sandlera@mail.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Information is also available on the Institute’s/Center’s home page: http:// deainfo.nci.nih.gov/advisory/pcp/index.htm, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) E:\FR\FM\19NON1.SGM 19NON1 Federal Register / Vol. 78, No. 223 / Tuesday, November 19, 2013 / Notices Dated: November 13, 2013. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. DEPARTMENT OF HOMELAND SECURITY [FR Doc. 2013–27597 Filed 11–18–13; 8:45 am] Executive Order 13650 Improving Chemical Facility Safety and Security Listening Sessions BILLING CODE 4140–01–P National Protection and Programs Directorate, DHS. ACTION: Notice of public listening sessions. AGENCY: DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of General Medical Sciences Amended; Notice of Meeting Notice is hereby given of a change in the meeting of the National Institute of General Medical Sciences Special Emphasis Panel, November 21, 2013, 12:00 p.m. to November 21, 2013, 5:00 p.m., National Institutes of Health, Natcher Building, 45 Center Drive, Room 3An. 18, Bethesda, MD 20892 which was published in the Federal Register on November 7, 2013, 78 FR 66947. The meeting will start on November 21, 2013 at 11:00 a.m. and end November 21, 2013 at 2:00 p.m. The meeting location remains the same. The meeting is closed to the public. Dated: November 13, 2013. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–27599 Filed 11–18–13; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health TKELLEY on DSK3SPTVN1PROD with NOTICES Center for Scientific Review; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Center for Scientific Review Special Emphasis Panel, October 03, 2013, 12:00 p.m. to October 03, 2013, 03:00 p.m., National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, which was published in the Federal Register on September 05, 2013, 78 FR 54665. The meeting will be held on November 25, 2013 from 04:30 p.m. to 07:30 p.m. The meeting location remains the same. The meeting is closed to the public. Dated: November 13, 2013. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–27589 Filed 11–18–13; 8:45 am] BILLING CODE 4140–01–P VerDate Mar<15>2010 17:21 Nov 18, 2013 Jkt 232001 [Docket No. DHS–2013–0075] The Department of Homeland Security (DHS), in coordination with the Department of Labor (DOL) and the Environmental Protection Agency (EPA), is announcing a series of public listening sessions and webinars to solicit comments and suggestions from stakeholders on issues pertaining to Improving Chemical Facility Safety and Security (Executive Order [EO] 13650). DATES: The public listening sessions will be held from 8:00 a.m. to 4:30 p.m. on the following dates: November 19, 2013, and December 11, 2013. Online webinars will be hosted November 25, 2013, and December 16, 2013. Additional listening sessions may be scheduled in December 2013 and January 2014. We will notify the public of the date(s), time(s), location(s), and other details of any such session(s) as soon as we have information available. Previous public listening sessions were held November 5, 2013 and November 15, 2013. ADDRESSES: The public listening sessions will be held at the following locations: • November 19, 2013, Illinois Emergency Management Agency, 2200 Dirksen Parkway, Springfield, IL 62703; and • December 11, 2013, Valencia Criminal Justice Institute, 8600 Valencia College Lane, Auditorium-150, Orlando, FL 32825. Note: Previous public listening sessions were held: • November 5, 2013, College of the Mainland, 1200 Amburn Road, Texas City, TX 77591, Learning Resource Center, Room 131; and • November 15, 2013, GSA’s ROB Auditorium, 301 7th Street SW., (7th and D Streets), Washington, DC 20407. Submit written comments to the DHS Docket Office, Docket No. DHS–2013– 0075, Technical Data Center, Room N– 2625, U.S. Department of Labor, 200 Constitution Avenue NW., Washington, DC 20210. Comments will also be accepted by email at: eo.chemical@ hq.dhs.gov. All comments should be identified with Docket No. DHS–2013– 0075. SUMMARY: PO 00000 Frm 00072 Fmt 4703 Sfmt 4703 69433 Registration to Attend and/or to Participate: If you wish to attend any public listening session and/or a Webinar and/or make an oral comment/ presentation at both the in-person and Webinar listening sessions, you must register at www.GovEvents.com. When registering, you must indicate that you wish to make a comment/presentation and indicate the related EO topic. Registration for those wishing to make comments will be on a first come, first served basis provided a cross-section of stakeholders are represented by the speakers. Comments are requested not to exceed five minutes. Actual schedule for the presentations will depend on the number of requests. There is no fee to register for the public listening sessions or Webinars. Same-day registration at a listening session is permitted but only on a space-available basis, beginning at 8:00 a.m. We will do our best to accommodate all persons who wish to make a comment/presentation at a listening session or webinar. The EO Working Group encourages persons and groups having similar interests to consolidate their information for presentation through a single representative. Each participant will be notified prior to the listening session or webinar of the approximate time that the participant’s comment/presentation is scheduled to begin. Registration for the in-person listening sessions and webinars can be found at www.GovEvents.com. FOR FURTHER INFORMATION CONTACT: For further information please email: eo.chemical@hq.dhs.gov. Individuals with access and functional needs wishing to attend the sessions and/or webinar and requiring accommodations should contact Kathryn Willcutts at Kathryn.Willcutts@hq.dhs.gov as soon as possible. SUPPLEMENTARY INFORMATION: I. Background On August 1, 2013, President Obama issued EO 13650 to improve chemical facility safety and security. The Working Group charged with implementing the EO is co-chaired by DHS, DOL, and EPA, and includes participation from the Departments of Justice, Agriculture, and Transportation. Obtaining stakeholder input is critical to the success of the EO. To that end, the EO Working Group is scheduling public listening sessions around the country, as well as several Webinars. Attendees will have an opportunity to provide input EO related on topics such as: Improving operational coordination with Federal, state, tribal, and local partners; enhanced information E:\FR\FM\19NON1.SGM 19NON1

Agencies

[Federal Register Volume 78, Number 223 (Tuesday, November 19, 2013)]
[Notices]
[Pages 69432-69433]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-27597]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
President's Cancer Panel.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.

    Name of Committee: President's Cancer Panel.
    Date: March 3, 2014.
    Time: 8:30 a.m. to 4:00 p.m.
    Agenda: Cancer Communication in the Digital Era: Opportunities 
and Challenges.
    Place: National Institutes of Health, 9000 Rockville Pike, 
Building 31, C-Wing, 6th Floor, Conference Room 10, Bethesda, MD 
20892.
    Contact Person: Abby B. Sandler, Ph.D., Executive Secretary, 
President's Cancer Panel, Special Assistant to the Director, NCI 
Center for Cancer Research, 9000 Rockville Pike, Building 31, Room 
B2B37, MSC 2590, Bethesda, MD 20892-8349, (301) 451-9399, 
sandlera@mail.nih.gov.
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    Information is also available on the Institute's/Center's home 
page: http://deainfo.nci.nih.gov/advisory/pcp/index.htm, where an 
agenda and any additional information for the meeting will be posted 
when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)


[[Page 69433]]


    Dated: November 13, 2013.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-27597 Filed 11-18-13; 8:45 am]
BILLING CODE 4140-01-P